VoxNeuro is a Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function. We are pushing the boundaries of brain health and empowering physicians with a breakthrough technology that delivers a comprehensive understanding of how a brain is functioning by measuring attention and concentration, information processing, and working memory. Our technology is based on thorough research, with more than 300 peer-reviewed publications on EEG, including numerous breakthrough findings, published by Chief Science Officer John F. Connolly, PhD, since 1982. VoxNeuro's research and innovation is a constant, and our technology will continue to advance the way brain health is managed. Learn more at voxneuro.com